AURX — Nuo Therapeutics, Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1091596 ·
Last close
$1.09
Market Cap
$52.79M
52W High
$2.29
52W Low
$0.77
ADV30
5,183
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,866,125 | 1,192,791 | -374,432 | -424,928 | 2,730,205 | 80,941 | 4,578,709 |
| Jun 2026 | 1,768,986 | 1,170,027 | -166,552 | -277,601 | 2,626,290 | 449,325 | 4,161,604 |
| Mar 2026 | 1,302,115 | 849,727 | -446,466 | -618,466 | 1,945,669 | 263,827 | 3,329,532 |
| Dec 2025 | 1,096,830 | 688,369 | -579,338 | -578,480 | 1,845,662 | 548,946 | 2,802,221 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,181,027
Investing CF
$-298,746
Financing CF
$1,675,000
CapEx
$-298,746
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.05
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-35,668,229
Inventory
$269,518
Receivables
$1,167,571
ST Investments
—
EBIT TTM
$-1,844,378
Pretax Income TTM
$-2,124,236
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,200,027
EBITDA
$-1,636,984
Free Cash Flow
$-1,647,782
Enterprise Value
$54,153,832
Total Cash
$449,325
Total Debt
$1,810,340
Shares Out
48,433,777
Trailing EPS
$-0.04
Book Value
$-0.03
ROE
—
ROA
-54.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,313,509 | -2,516,649 | -2,512,216 | 1,845,662 | 2,802,221 | -956,559 | -864,971 |
| Dec 2024 | 1,365,173 | -2,457,835 | -2,323,705 | 1,189,508 | 675,796 | 513,712 | -2,231,622 |
| Dec 2023 | 608,525 | -3,168,274 | -3,171,436 | 1,877,880 | 838,732 | 1,039,148 | -3,167,782 |
| Dec 2022 | 112,250 | -3,320,594 | -3,171,736 | 3,047,360 | 856,022 | 2,191,338 | -3,706,126 |
TTM Snapshot
Revenues TTM
$5,200,027
NetIncome TTM
$-2,012,466
OpCashFlow TTM
—
Assets (Latest)
$2,626,290
Forward EPS
$-0.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| COCH | Envoy Medical, Inc. | $53.20M | $6.87 | — |
| HYPR | Hyperfine, Inc. | $51.10M | $0.56 | — |
| RNXT | RenovoRx, Inc. | $50.18M | $1.04 | — |
| POSC | POSITRON CORP | $55.84M | $1.70 | — |
| CNXU | Conexeu Sciences Inc. | $56.41M | $2.00 | — |
News headlines (Yahoo Finance, 1h cache)
Nuo Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
2026-11-16 13:30 · Yahoo
Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
2026-08-17 12:00 · Yahoo
Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.